AFL:NYE-Aflac Incorporated (USD)

COMMON STOCK | Insurance—Life | NYE

Last Closing Price

USD 36.35

Change

+0.33 (+0.92)%

Market Cap

USD 25.72B

Volume

3.92M

Average Target Price

USD 42.00 (+15.54%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-30 )

Largest Industry Peers for Insurance—Life

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LFC China Life Insurance Company L..

+0.05 (+0.44%)

USD155.47B 8.42 N/A
MET-PE MetLife, Inc

N/A

USD49.20B 4.12 N/A
MET-PA MetLife, Inc

-0.30 (-1.18%)

USD48.66B 3.65 N/A
PUK Prudential plc

-0.57 (-1.95%)

USD37.94B 28.02 N/A
MET MetLife, Inc

+0.40 (+1.09%)

USD33.52B 4.62 N/A
MFC Manulife Financial Corporation

+0.01 (+0.07%)

USD26.99B 9.30 N/A
PRU Prudential Financial, Inc

+0.43 (+0.68%)

USD24.92B 8.85 N/A
GL Globe Life Inc

+0.89 (+1.13%)

USD8.51B 11.71 N/A
LNC Lincoln National Corporation

+0.39 (+1.26%)

USD5.98B 27.40 N/A
PRI Primerica, Inc

+0.20 (+0.18%)

USD4.48B 12.69 N/A

ETFs Containing AFL

Symbol Name Weight Mer Price(Change) Market Cap
CORP PIMCO Investment Grade Co.. 0.00 % 0.20 %

-0.26 (-0.23%)

USD0.78B
FLI:CA CI First Asset U.S. & Can.. 0.00 % 0.75 %

+0.04 (+0.55%)

USD0.07B
IAK iShares U.S. Insurance ET.. 0.00 % 0.43 %

+0.46 (+0.83%)

USD0.06B
VLIQ:LSE Vanguard Global Liquidity.. 0.00 % 0.00 %

+0.03 (+0.12%)

USD0.01B
VLIQ:XETRA Vanguard Global Liquidity.. 0.00 % 0.00 %

+0.22 (+0.74%)

USD0.01B

Market Performance

  Market Performance vs.
Industry/Classification (Insurance—Life)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -31.29% 33% F 22% F
Dividend Return 1.59% 33% F 47% F
Total Return -29.70% 22% F 22% F
Trailing 12 Months  
Capital Gain -28.13% 22% F 22% F
Dividend Return 2.19% 33% F 46% F
Total Return -25.94% 22% F 21% F
Trailing 5 Years  
Capital Gain 24.34% 87% B+ 66% D
Dividend Return 15.87% 62% D- 52% F
Total Return 40.21% 87% B+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.62% N/A N/A 77% C+
Dividend Return 2.26% N/A N/A 57% F
Total Return 10.88% N/A N/A 76% C
Risk Return Profile  
Volatility (Standard Deviation) 17.25% N/A N/A 47% F
Risk Adjusted Return 63.06% N/A N/A 76% C
Market Capitalization 25.72B 72% C- 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Insurance—Life)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.93 56% F 77% C+
Price/Book Ratio 0.87 47% F 69% D+
Price / Cash Flow Ratio 4.71 28% F 56% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 10.16% 78% C+ 68% D+
Return on Invested Capital 10.23% 72% C- 73% C
Return on Assets 1.67% 89% B+ 44% F
Debt to Equity Ratio 22.13% 56% F 79% C+
Technical Ratios  
Short Ratio 3.23 56% F 36% F
Short Percent 1.51% 79% C+ 77% C+
Beta 0.82 78% C+ 67% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.